ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishSK Hynix
26 Jun 2020 06:18

SK Hynix:  Strong Positioning Among Asia Ex-Japan Funds.

Ownership levels in SK Hynix are on the increase. Today's average weights and funds held % are at multi-year highs among Asia Ex-Japan active...

Logo
314 Views
Share
21 Jun 2020 08:11

Asia Short Interest Weekly - Covering HK Consumer Discretionary, Shorting Japan Consumer Staples

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
284 Views
Share
13 Jun 2020 10:42

Asia Short Interest Weekly - Shorts Covered as Markets Melted Up

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
450 Views
Share
12 Jun 2020 16:26

Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion

The Japanese drug maker, Takeda Pharmaceutical (4502 JP)  announced yesterday (11th June 2020) that it has entered into an agreement to divest a...

Share
07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
321 Views
Share
x